Literature DB >> 26278106

DNAJC13 p.Asn855Ser mutation screening in Parkinson's disease and pathologically confirmed Lewy body disease patients.

O Lorenzo-Betancor1, K Ogaki1, A I Soto-Ortolaza1, C Labbe1, R L Walton1, A J Strongosky2, J A van Gerpen2, R J Uitti2, P J McLean1, W Springer1, J Siuda3, G Opala3, A Krygowska-Wajs4, M Barcikowska5, K Czyzewski6, A McCarthy7, T Lynch7, A Puschmann8,9, I Rektorova10, Y Sanotsky11, C Vilariño-Güell12, M J Farrer12, T J Ferman13, B F Boeve14, R C Petersen14, J E Parisi15, N R Graff-Radford2, D W Dickson1,16, Z K Wszolek2, O A Ross1.   

Abstract

BACKGROUND: Recently, a novel mutation in exon 24 of DNAJC13 gene (p.Asn855Ser, rs387907571) has been reported to cause autosomal dominant Parkinson's disease (PD) in a multi-incident Mennonite family.
METHODS: In the present study the mutation containing exon of the DNAJC13 gene has been sequenced in a Caucasian series consisting of 1938 patients with clinical PD and 838 with pathologically diagnosed Lewy body disease (LBD).
RESULTS: Our sequence analysis did not identify any coding variants in exon 24 of DNAJC13. Two previously described variants in intron 23 (rs200204728 and rs2369796) were observed.
CONCLUSION: Our results indicate that the region surrounding the DNAJC13 p.Asn855Ser substitution is highly conserved and mutations in this exon are not a common cause of PD or LBD among Caucasian populations.
© 2015 EAN.

Entities:  

Keywords:  DNAJC13; Lewy body disease; Parkinson's disease; genetics

Mesh:

Substances:

Year:  2015        PMID: 26278106      PMCID: PMC4542017          DOI: 10.1111/ene.12770

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  12 in total

1.  DNAJC13 genetic variants in parkinsonism.

Authors:  Emil K Gustavsson; Joanne Trinh; Ilaria Guella; Carles Vilariño-Güell; Silke Appel-Cresswell; A Jon Stoessl; Joseph K Tsui; Martin McKeown; Alex Rajput; Ali H Rajput; Jan O Aasly; Matthew J Farrer
Journal:  Mov Disord       Date:  2014-11-12       Impact factor: 10.338

2.  Clinical, positron emission tomography, and pathological studies of DNAJC13 p.N855S Parkinsonism.

Authors:  Silke Appel-Cresswell; Ali H Rajput; Vesna Sossi; Christina Thompson; Vanessa Silva; Jessamyn McKenzie; Katherine Dinelle; Siobhan E McCormick; Carles Vilariño-Güell; A Jon Stoessl; Dennis W Dickson; Chris A Robinson; Matthew J Farrer; Alex Rajput
Journal:  Mov Disord       Date:  2014-09-03       Impact factor: 10.338

3.  The DnaJ-domain protein RME-8 functions in endosomal trafficking.

Authors:  Martine Girard; Viviane Poupon; Francois Blondeau; Peter S McPherson
Journal:  J Biol Chem       Date:  2005-09-22       Impact factor: 5.157

4.  VPS35 and DNAJC13 disease-causing variants in essential tremor.

Authors:  Alex Rajput; Jay P Ross; Cecily Q Bernales; Sruti Rayaprolu; Alexandra I Soto-Ortolaza; Owen A Ross; Jay van Gerpen; Ryan J Uitti; Zbigniew K Wszolek; Ali H Rajput; Carles Vilariño-Güell
Journal:  Eur J Hum Genet       Date:  2014-08-13       Impact factor: 4.246

5.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

6.  DNAJC13 mutations in Parkinson disease.

Authors:  Carles Vilariño-Güell; Alex Rajput; Austen J Milnerwood; Brinda Shah; Chelsea Szu-Tu; Joanne Trinh; Irene Yu; Mary Encarnacion; Lise N Munsie; Lucia Tapia; Emil K Gustavsson; Patrick Chou; Igor Tatarnikov; Daniel M Evans; Frederick T Pishotta; Mattia Volta; Dayne Beccano-Kelly; Christina Thompson; Michelle K Lin; Holly E Sherman; Heather J Han; Bruce L Guenther; Wyeth W Wasserman; Virginie Bernard; Colin J Ross; Silke Appel-Cresswell; A Jon Stoessl; Christopher A Robinson; Dennis W Dickson; Owen A Ross; Zbigniew K Wszolek; Jan O Aasly; Ruey-Meei Wu; Faycal Hentati; Rachel A Gibson; Peter S McPherson; Martine Girard; Michele Rajput; Ali H Rajput; Matthew J Farrer
Journal:  Hum Mol Genet       Date:  2013-11-11       Impact factor: 6.150

7.  Analysis of articulation between clathrin and retromer in retrograde sorting on early endosomes.

Authors:  Vincent Popoff; Gonzalo A Mardones; Siau-Kun Bai; Valérie Chambon; Danièle Tenza; Patricia V Burgos; Anbing Shi; Philippe Benaroch; Sylvie Urbé; Christophe Lamaze; Barth D Grant; Graça Raposo; Ludger Johannes
Journal:  Traffic       Date:  2009-10-05       Impact factor: 6.215

Review 8.  Genetics of Parkinson's disease--state of the art, 2013.

Authors:  Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 9.  Genetics of Parkinson's disease: the yield.

Authors:  Marianna Spatola; Christian Wider
Journal:  Parkinsonism Relat Disord       Date:  2014-01       Impact factor: 4.891

Review 10.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

View more
  9 in total

1.  TMEM230 in Parkinson's disease.

Authors:  Laura Ibanez; Umber Dube; John Budde; Kathleen Black; Alexandra Medvedeva; Albert A Davis; Joel S Perlmutter; Bruno A Benitez; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2017-03-16       Impact factor: 4.673

2.  Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.

Authors:  Prabhjyot Saini; Uladzislau Rudakou; Eric Yu; Jennifer A Ruskey; Farnaz Asayesh; Sandra B Laurent; Dan Spiegelman; Stanley Fahn; Cheryl Waters; Oury Monchi; Yves Dauvilliers; Nicolas Dupré; Lior Greenbaum; Sharon Hassin-Baer; Alberto J Espay; Guy A Rouleau; Roy N Alcalay; Edward A Fon; Ronald B Postuma; Ziv Gan-Or
Journal:  Neurobiol Aging       Date:  2020-10-31       Impact factor: 4.673

Review 3.  DNAJC proteins and pathways to parkinsonism.

Authors:  Dorien A Roosen; Cornelis Blauwendraat; Mark R Cookson; Patrick A Lewis
Journal:  FEBS J       Date:  2019-06-20       Impact factor: 5.622

Review 4.  DnaJ/Hsp40 Family and Parkinson's Disease.

Authors:  Takafumi Hasegawa; Shun Yoshida; Naoto Sugeno; Junpei Kobayashi; Masashi Aoki
Journal:  Front Neurosci       Date:  2018-01-10       Impact factor: 4.677

Review 5.  New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.

Authors:  Andreas Puschmann
Journal:  Curr Neurol Neurosci Rep       Date:  2017-09       Impact factor: 5.081

Review 6.  The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions.

Authors:  Tatiana Orme; Rita Guerreiro; Jose Bras
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-10       Impact factor: 5.081

7.  Putative second hit rare genetic variants in families with seemingly GBA-associated Parkinson's disease.

Authors:  Muhammad Aslam; Nirosiya Kandasamy; Anwar Ullah; Nagarajan Paramasivam; Mehmet Ali Öztürk; Saima Naureen; Abida Arshad; Mazhar Badshah; Kafaitullah Khan; Muhammad Wajid; Rashda Abbasi; Muhammad Ilyas; Roland Eils; Matthias Schlesner; Rebecca C Wade; Nafees Ahmad; Jakob von Engelhardt
Journal:  NPJ Genom Med       Date:  2021-01-05       Impact factor: 8.617

Review 8.  DNAJ Proteins in neurodegeneration: essential and protective factors.

Authors:  Christina Zarouchlioti; David A Parfitt; Wenwen Li; Lauren M Gittings; Michael E Cheetham
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

Review 9.  Vesicular Dysfunction and the Pathogenesis of Parkinson's Disease: Clues From Genetic Studies.

Authors:  Kirsten Ebanks; Patrick A Lewis; Rina Bandopadhyay
Journal:  Front Neurosci       Date:  2020-01-08       Impact factor: 4.677

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.